Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Cash & Current Investments (2020 - 2026)

NeuroPace has reported Cash & Current Investments over the past 7 years, most recently at $54.0 million for Q1 2026.

  • For Q1 2026, Cash & Current Investments fell 18.53% year-over-year to $54.0 million; the TTM value through Mar 2026 reached $54.0 million, down 18.53%, while the annual FY2025 figure was $61.1 million, 15.74% up from the prior year.
  • Cash & Current Investments for Q1 2026 was $54.0 million at NeuroPace, down from $61.1 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $103.2 million in Q1 2022 and troughed at $52.8 million in Q4 2024.
  • A 5-year average of $67.3 million and a median of $62.1 million in 2025 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: surged 237.95% in 2022 and later plummeted 34.47% in 2023.
  • Year by year, Cash & Current Investments stood at $77.4 million in 2022, then dropped by 14.15% to $66.5 million in 2023, then dropped by 20.61% to $52.8 million in 2024, then grew by 15.74% to $61.1 million in 2025, then fell by 11.59% to $54.0 million in 2026.
  • Business Quant data shows Cash & Current Investments for NPCE at $54.0 million in Q1 2026, $61.1 million in Q4 2025, and $60.0 million in Q3 2025.